| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |